TY - JOUR
T1 - Tumor control in long-term survivors following superficial hyperthermia
AU - Myerson, Robert J.
AU - Perez, Carlos A.
AU - Emami, Bahman
AU - Straube, William
AU - Kuske, Robert R.
AU - Leybovich, Leonid
AU - Von Gerichten, Debra
N1 - Funding Information:
Robert J. Myerson, Ph.D., M.D. is the recipient of American Cancer Society Career Development Award No. 85-33. Accepted for publication 16 November 1989.
PY - 1990/5
Y1 - 1990/5
N2 - Sixty tumors with a minimum of 1-year follow-up were treated with radiation and superficial microwave hyperthermia (915 MHz). The overall local control rate was 50% ( 30 60). The most important factor in outcome was appropriateness of the hyperthermia applicator. Tumors covered by at least the 25% iso-SAR contour achieved 65% local control versus 21% local control with less than 25% SAR coverage (p < 0.01). Several measures of adequate minimum monitored tumor temperature and duration were considered. The measure best correlated with outcome was best single session time at or above 43°C (t43). If each monitored tumor catheter achieved t43 ≥ 30 minutes in at least one session, then tumor control was significantly (p < 0.01) improved (63% with Min t43 ≥ 30 versus 25% with Min t43 < 30). Although there was considerable overlap between tumors with SAR ≥ 25% and those achieving Min t43 ≥ 30, a statistically significant (p = 0.02) difference could be demonstrated between the group meeting both the SAR and the minimum tumor time/duration standards as opposed to those meeting only one standard. The actuarial local progression-free survival for tumors most likely to have had adequate hyperthermia (defined as SAR ≥ 25% and Min t43 > 30) and all other tumors did not begin to separate significantly until 8 to 12 months after treatment. Implications for future randomized studies are discussed.
AB - Sixty tumors with a minimum of 1-year follow-up were treated with radiation and superficial microwave hyperthermia (915 MHz). The overall local control rate was 50% ( 30 60). The most important factor in outcome was appropriateness of the hyperthermia applicator. Tumors covered by at least the 25% iso-SAR contour achieved 65% local control versus 21% local control with less than 25% SAR coverage (p < 0.01). Several measures of adequate minimum monitored tumor temperature and duration were considered. The measure best correlated with outcome was best single session time at or above 43°C (t43). If each monitored tumor catheter achieved t43 ≥ 30 minutes in at least one session, then tumor control was significantly (p < 0.01) improved (63% with Min t43 ≥ 30 versus 25% with Min t43 < 30). Although there was considerable overlap between tumors with SAR ≥ 25% and those achieving Min t43 ≥ 30, a statistically significant (p = 0.02) difference could be demonstrated between the group meeting both the SAR and the minimum tumor time/duration standards as opposed to those meeting only one standard. The actuarial local progression-free survival for tumors most likely to have had adequate hyperthermia (defined as SAR ≥ 25% and Min t43 > 30) and all other tumors did not begin to separate significantly until 8 to 12 months after treatment. Implications for future randomized studies are discussed.
KW - Hyperthermia physics
KW - Microwave hyperthermia
KW - Superficial hyperthermia
UR - http://www.scopus.com/inward/record.url?scp=0025346806&partnerID=8YFLogxK
U2 - 10.1016/0360-3016(90)90448-S
DO - 10.1016/0360-3016(90)90448-S
M3 - Article
C2 - 2347720
AN - SCOPUS:0025346806
SN - 0360-3016
VL - 18
SP - 1123
EP - 1129
JO - International journal of radiation oncology, biology, physics
JF - International journal of radiation oncology, biology, physics
IS - 5
ER -